NARI Inari Medical Inc

Price (delayed)

$47.98

Market cap

$2.78B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.03

Enterprise value

$2.77B

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, ...

Highlights
The EPS has surged by 95% year-on-year and by 25% since the previous quarter
NARI's net income has soared by 94% year-on-year and by 41% since the previous quarter
The quick ratio has plunged by 64% YoY and by 62% from the previous quarter

Key stats

What are the main financial stats of NARI
Market
Shares outstanding
57.96M
Market cap
$2.78B
Enterprise value
$2.77B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.94
Price to sales (P/S)
5.52
EV/EBIT
624.45
EV/EBITDA
182.76
EV/Sales
5.62
Earnings
Revenue
$493.63M
EBIT
$4.44M
EBITDA
$15.18M
Free cash flow
$29.73M
Per share
EPS
-$0.03
Free cash flow per share
$0.52
Book value per share
$8.07
Revenue per share
$8.7
TBVPS
$5.44
Balance sheet
Total assets
$674.24M
Total liabilities
$209.33M
Debt
$32.05M
Equity
$464.91M
Working capital
$159.22M
Liquidity
Debt to equity
0.07
Current ratio
3.09
Quick ratio
2.44
Net debt/EBITDA
-0.47
Margins
EBITDA margin
3.1%
Gross margin
88%
Net margin
-0.3%
Operating margin
-2.8%
Efficiency
Return on assets
-0.3%
Return on equity
-0.4%
Return on invested capital
1.2%
Return on capital employed
0.7%
Return on sales
0.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NARI stock price

How has the Inari Medical stock price performed over time
Intraday
1.22%
1 week
6.1%
1 month
-17.65%
1 year
-23.17%
YTD
-26.09%
QTD
-26.09%

Financial performance

How have Inari Medical's revenue and profit performed over time
Revenue
$493.63M
Gross profit
$434.56M
Operating income
-$14.03M
Net income
-$1.64M
Gross margin
88%
Net margin
-0.3%
Inari Medical's net margin has soared by 96% YoY and by 50% from the previous quarter
NARI's net income has soared by 94% year-on-year and by 41% since the previous quarter
The company's operating margin has surged by 62% YoY but it fell by 22% QoQ
The operating income has soared by 50% YoY but it has contracted by 32% from the previous quarter

Growth

What is Inari Medical's growth rate over time

Valuation

What is Inari Medical stock price valuation
P/E
N/A
P/B
5.94
P/S
5.52
EV/EBIT
624.45
EV/EBITDA
182.76
EV/Sales
5.62
The EPS has surged by 95% year-on-year and by 25% since the previous quarter
The price to book (P/B) is 26% lower than the last 4 quarters average of 8.0
The equity is up by 11% year-on-year and by 2.8% since the previous quarter
The P/S is 29% below the last 4 quarters average of 7.8
The revenue rose by 29% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Inari Medical business performance
NARI's return on invested capital has surged by 117% year-on-year and by 71% since the previous quarter
The return on sales has surged by 113% year-on-year and by 50% since the previous quarter
The company's return on assets has surged by 95% YoY and by 40% QoQ
The return on equity has surged by 94% year-on-year and by 33% since the previous quarter

Dividends

What is NARI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NARI.

Financial health

How did Inari Medical financials performed over time
The company's total liabilities has surged by 140% YoY and by 116% QoQ
The quick ratio has plunged by 64% YoY and by 62% from the previous quarter
Inari Medical's debt is 93% less than its equity
NARI's debt to equity is down by 13% YoY
The equity is up by 11% year-on-year and by 2.8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.